Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal midazolam with or without topical lidocaine for pediatric blood draw and lumbar puncture success
IRCT20151003024317N13Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in procedural distress comparing Intranasal midazolam + topical lidocaine with Intranasal midazolam alone (2 arms). Primary endpoints: Respiratory disorders, Pain intensity and 1 more. Started Feb 2022; status: completed.
02
Drugs
midazolamlidocaine
03
Conditions
procedural distress
Beyond the preview
Go deeper on IRCT20151003024317N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151003024317N13.